Targeted cell delivery of mesenchymal stem cell therapy for cardiovascular disease applications: a review of preclinical advancements

Cardiovascular diseases (CVD) continue to be the leading cause of morbidity and mortality globally and claim the lives of over 17 million people annually. Current management of CVD includes risk factor modification and preventative strategies including dietary and lifestyle changes, smoking cessatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Huerta, Carlos Theodore, Voza, Francesca A., Ortiz, Yulexi Y., Liu, Zhao-Jun, Velazquez, Omaida C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10436297/
https://www.ncbi.nlm.nih.gov/pubmed/37600026
http://dx.doi.org/10.3389/fcvm.2023.1236345

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10436297/
https://www.ncbi.nlm.nih.gov/pubmed/37600026
http://dx.doi.org/10.3389/fcvm.2023.1236345

Ejemplares similares